Bimetallic clusterzymes-loaded dendritic mesoporous silica particle regulate arthritis microenvironment via ROS scavenging and YAP1 stabilization
Authors:
Open Access
- 1 December 2024
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 42, 613-627
Abstract
Clusterzymes are synthetic enzymes exhibiting substantial catalytic activity and selectivity, which are uniquely driven by single-atom constructs. A dramatic increase in antioxidant capacity, 158 times more than natural trolox, is noted when single-atom copper is incorporated into gold-based clusterzymes to form Au24Cu1. Considering the inflammatory and mildly acidic microenvironment characteristic of osteoarthritis (OA), pH-dependent dendritic mesoporous silica nanoparticles (DMSNs) coupled with PEG have been employed as a delivery system for the spatial-temporal release of clusterzymes within active articular regions, thereby enhancing the duration of effectiveness. Nonetheless, achieving high therapeutic efficacy remains a significant challenge. Herein, we describe the construction of a Clusterzymes-DMSNs-PEG complex (CDP) which remarkably diminishes reactive oxygen species (ROS) and stabilizes the chondroprotective protein YAP by inhibiting the Hippo pathway. In the rabbit ACLT (anterior cruciate ligament transection) model, the CDP complex demonstrated inhibition of matrix metalloproteinase activity, preservation of type II collagen and aggregation protein secretion, thus prolonging the clusterzymes' protective influence on joint cartilage structure. Our research underscores the efficacy of the CDP complex in ROS-scavenging, enabled by the release of clusterzymes in response to an inflammatory and slightly acidic environment, leading to the obstruction of the Hippo pathway and downstream NF-κB signaling pathway. This study illuminates the design, composition, and use of DMSNs and clusterzymes in biomedicine, thus charting a promising course for the development of novel therapeutic strategies in alleviating OA.Keywords
Funding Information
- National Natural Science Foundation of China (82470903)
- Natural Science Foundation of Zhejiang Province (LY24C110001, LY22H060003)
This publication has 64 references indexed in Scilit:
- Nature and Strength of M−S Bonds (M = Au, Ag, and Cu) in Binary Alloy Gold ClustersThe Journal of Physical Chemistry A, 2010
- Icosahedral Crown Gold Nanocluster Au43Cu12 with High Catalytic ActivityNano Letters, 2010
- Interactions between Sox9 and β-catenin control chondrocyte differentiationGenes & Development, 2004
- Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytesTrends in Immunology, 2002
- Expression of Early and Late Differentiation Markers (Proliferating Cell Nuclear Antigen, Syndecan-3, Annexin VI, and Alkaline Phosphatase) by Human Osteoarthritic ChondrocytesThe American Journal of Pathology, 2001
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999
- Signal-induced ubiquitination of Ikappa Balpha by the F-box protein Slimb/beta -TrCPGenes & Development, 1999
- Identification of the receptor component of the IκBα–ubiquitin ligaseNature, 1998
- Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.Journal of Clinical Investigation, 1997
- Type x collagen synthesis in human osteoarthritic cartilage. indication of chondrocyte hypertrophyArthritis & Rheumatism, 1992